Who is sponsoring NCT06007196?

NCT06007196 is sponsored by Medical University of Vienna.

What drugs are being tested in NCT06007196?

Interventions in NCT06007196: non-invasive device (Task Force CORE(R) and Task Force CARDIO(R).

What condition does NCT06007196 study?

NCT06007196 studies Hemodynamic Measurement, Non-invasive, Cardiac Output.

Is NCT06007196 still recruiting?

NCT06007196 is currently status unknown. Last updated 25 August 2023.

Last reviewed 2023-08-25 · How we verify

NCT06007196

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Non-invasive Continuous Hemodynamic Measurement From Task Force CORE

Status unknown Last updated 25 August 2023

What this trial tests

trial testing non-invasive device (Task Force CORE(R) and Task Force CARDIO(R) in Hemodynamic Measurement in 70 participants. Status unknown.

Timeline

1 September 2023

Primary endpoint
31 August 2024

30 September 2024

Quick facts

Lead sponsor	Medical University of Vienna
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	70
Start date	1 September 2023
Primary completion	31 August 2024
Estimated completion	30 September 2024
Sites	1 location across Austria

Drugs / interventions tested

non-invasive device (Task Force CORE(R) and Task Force CARDIO(R)

Conditions studied

Hemodynamic Measurement — all drugs for Hemodynamic Measurement →
Non-invasive — all drugs for Non-invasive →
Cardiac Output — all drugs for Cardiac Output →

Sponsor

Medical University of Vienna

Who can join

18 and older, any sex, with Hemodynamic Measurement or Non-invasive. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Validation of hemodynamic measurements using the non-invasive Task Force Core(R) and Task Force Cardio(R) device with invasive hemodynamic measurements using the thermodilution technique (PICCO device).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Medical University of Vienna trials

Trials by the same sponsor.

NCT07473401 — Retinal Oxygen Metabolism in Children With Myopia · not yet recruiting
NCT07511400 — The Role of NaV1.8 in Human Pain Models · EARLY_PHASE1 · not yet recruiting
NCT07516990 — Intramuscular Injection of Mashed Parathyroid Tissue Into a Forearm During Thyroid Surgery to Prevent Permanent Postoper · NA · recruiting
NCT07496437 — Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? · NA · not yet recruiting
NCT07290712 — Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06007196 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Vienna
Last refreshed: 25 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06007196.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing